Avidity Biosciences Stock In The News
| RNA Stock | USD 32.05 0.05 0.16% |
Our overall analysis of Avidity Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Avidity Biosciences. The specific impact of Avidity Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Avidity Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Avidity Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Avidity Biosciences Backtesting and Avidity Biosciences Hype Analysis. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Avidity and other traded companies coverage with news coverage. We help investors stay connected with Avidity headlines for the 26th of March to make an informed investment decision based on correlating the impacts of news items on Avidity Stock performance. Please note that trading solely based on the Avidity Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Avidity |
Avidity Biosciences Today Top News and Investor Outlook
Avidity Biosciences Past News Timeline
Avidity Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Avidity earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Avidity Biosciences that are available to investors today. That information is available publicly through Avidity media outlets and privately through word of mouth or via Avidity internal channels. However, regardless of the origin, that massive amount of Avidity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avidity Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avidity Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avidity Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avidity Biosciences alpha.
Avidity Largest EPS Surprises
Earnings surprises can significantly impact Avidity Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2014-06-30 | 2014-06-30 | -0.25 | -0.22 | 0.03 | 12 | ||
2020-11-10 | 2020-09-30 | -0.37 | -0.31 | 0.06 | 16 | ||
2014-09-30 | 2014-09-30 | -0.23 | -0.29 | -0.06 | 26 | ||
2021-05-12 | 2021-03-31 | -0.56 | -0.64 | -0.08 | 14 | ||
2022-05-10 | 2022-03-31 | -0.8 | -0.71 | 0.09 | 11 | ||
2021-03-15 | 2020-12-31 | -0.34 | -0.43 | -0.09 | 26 |
Avidity Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Avidity Biosciences Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
25th of March 2025
TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering at finance.yahoo.com
20th of March 2025
Disposition of 7778 shares by Teresa McCarthy of Avidity Biosciences at 31.0598 subject to... at thelincolnianonline.com
17th of March 2025
Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circu... at prnewswire.com
14th of March 2025
Circulating DNA RNA Patent Landscape Report and Forecast 2024-2032 Nantomics, Genentech, a... at globenewswire.com
12th of March 2025
Dyne Therapeutics 4.3 Billion Peak Sales Potential Analyst Highlights Key Strengths And Ri... at benzinga.com
11th of March 2025
Disposition of 20000 shares by W Flanagan of Avidity Biosciences at 30.1307 subject to Rul... at finance.yahoo.com
7th of March 2025
Avidity Biosciences Earns Sector Outperform Rating from Analysts at Scotiabank at thelincolnianonline.com
4th of March 2025
NTx Appoints Seasoned Biotech Executive Joan Haab as Chief Operations Officer at finance.yahoo.com
3rd of March 2025
Disposition of 5875 shares by Kathleen Gallagher of Avidity Biosciences at 14.7 subject to... at MacroaxisInsider
21st of February 2025
New England Biolabs to Present Latest Innovations in Next Generation Sequencing Sample Pre... at finance.yahoo.com
28th of January 2025
miRecule and GBI Biomanufacturing Announce Strategic Partnership to Advance Development of... at finance.yahoo.com
15th of January 2025
Simnova and Orna Expand Strategic Partnership to Include BCMA-Targeted RNA Therapeutics at prnewswire.com
Avidity Biosciences Investors Sentiment
The influence of Avidity Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Avidity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Avidity Biosciences' public news can be used to forecast risks associated with an investment in Avidity. The trend in average sentiment can be used to explain how an investor holding Avidity can time the market purely based on public headlines and social activities around Avidity Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Avidity Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Avidity Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Avidity Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Avidity Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avidity Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avidity Biosciences' short interest history, or implied volatility extrapolated from Avidity Biosciences options trading.
Check out Avidity Biosciences Backtesting and Avidity Biosciences Hype Analysis. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.89) | Revenue Per Share | Quarterly Revenue Growth 0.356 | Return On Assets | Return On Equity |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.